









Mercados
/
Ações
/
nasdaq-livn
/

LivaNova PLC

LIVN

42.530USD

+1.400+3.40%

Horário de mercado （ET）Cotações atrasadas em 15 min

2.32BValor de mercado

PerdaP/L TTM



LivaNova PLC

42.530

+1.400+3.40%

Visão Geral Empresa Serviços Financeiros

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Informações da empresa

Código da empresaLIVN

Nome da EmpresaLivaNova PLC

Data de listagemOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Número de funcionários2900

Tipo de títulosOrdinary Share

Fim do ano fiscalOct 19

Endereço20 Eastbourne Terrace

CidadeLONDON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited Kingdom

Código postalW2 6LG

Telefone442033250662

Sitehttps://www.livanova.com/

Código da empresaLIVN

Data de listagemOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.15K

+2.76%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sem dados

Por RegiãoUSD

Nome

Receita

Proporção

United States

169.16M

53.39%

Rest of World

87.99M

27.77%

Europe

59.70M

18.84%

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: sáb, 17 de mai

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

Tipos de investidores

Investidores

Proporção

Investment Advisor

50.40%

Investment Advisor/Hedge Fund

30.34%

Hedge Fund

15.63%

Research Firm

3.10%

Pension Fund

1.48%

Bank and Trust

1.30%

Venture Capital

0.73%

Individual Investor

0.38%

Sovereign Wealth Fund

0.22%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

563

56.51M

103.64%

-7.03M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

2023Q1

544

57.05M

106.52%

-4.67M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

6.53M

11.97%

-36.05K

-0.55%

Mar 31, 2025

PRIMECAP Management Company

4.61M

8.45%

-145.65K

-3.06%

Mar 31, 2025

The Vanguard Group, Inc.

2.65M

4.87%

+316.99K

+13.56%

Mar 31, 2025

State Street Global Advisors (US)

2.10M

3.85%

-950.00

-0.05%

Mar 31, 2025

Capital Research Global Investors

2.08M

3.81%

+465.61K

+28.87%

Mar 31, 2025

Millennium Management LLC

2.07M

3.79%

-983.66K

-32.27%

Mar 31, 2025

AQR Capital Management, LLC

1.57M

2.88%

+829.12K

+111.71%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.41M

2.59%

+73.94K

+5.53%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.33M

2.44%

+20.96K

+1.60%

Mar 31, 2025

Emerald Advisers LLC

1.22M

2.24%

-5.17K

-0.42%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 2 de ago

Nome

Proporção

SPDR S&P Health Care Equipment ETF

1.76%

JPMorgan Active Small Cap Value ETF

1.01%

Invesco NASDAQ Future Gen 200 ETF

0.47%

Global X Aging Population ETF

0.35%

Federated Hermes MDT Small Cap Core ETF

0.31%

Avantis US Small Cap Equity ETF

0.31%

Simplify Health Care ETF

0.29%

iShares U.S. Medical Devices ETF

0.28%

First Trust Active Factor Mid Cap ETF

0.26%

WisdomTree US SmallCap Fund

0.25%

Ver Mais

SPDR S&P Health Care Equipment ETF

Proporção1.76%

JPMorgan Active Small Cap Value ETF

Proporção1.01%

Invesco NASDAQ Future Gen 200 ETF

Proporção0.47%

Global X Aging Population ETF

Proporção0.35%

Federated Hermes MDT Small Cap Core ETF

Proporção0.31%

Avantis US Small Cap Equity ETF

Proporção0.31%

Simplify Health Care ETF

Proporção0.29%

iShares U.S. Medical Devices ETF

Proporção0.28%

First Trust Active Factor Mid Cap ETF

Proporção0.26%

WisdomTree US SmallCap Fund

Proporção0.25%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

